| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |